Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2012
05/31/2012US20120135468 Beta-galactosidase derived from bacillus circulans
05/31/2012US20120135463 Rhamnose promoter expression system
05/31/2012US20120135460 Recombinant porcine chymotrypsin
05/31/2012US20120135447 Nucleic acids encoding t2r, a novel family of taste receptors
05/31/2012US20120135418 Automatic Detection Kit for Detecting HLA Alleles Using Real-Time Polymerase Chain Reaction
05/31/2012US20120135411 Pyrococcus furiosus strains and methods of using same
05/31/2012US20120135400 Novel Fluorescent and Colored Proteins, and Polynucleotides that Encode These Proteins
05/31/2012US20120135038 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines
05/31/2012US20120135037 Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
05/31/2012US20120135034 Non-Integrating Retroviral Vector Vaccines
05/31/2012US20120135033 Multiple delivery system for heterologous antigens
05/31/2012US20120135031 Method of enhancing an immune response
05/31/2012US20120135028 Vaccine
05/31/2012US20120135027 Proteins used for the diagnosis of lyme borreliosis
05/31/2012US20120135026 Combination neisserial compositions
05/31/2012US20120135025 Chlamydia antigens and uses thereof
05/31/2012US20120135024 Neisseria meningitidis antigens and compositions
05/31/2012US20120135022 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essentially consisting of vp3
05/31/2012US20120135020 Ttk peptides and vaccines including the same
05/31/2012US20120135015 Induction of Pancreatic Stem Cells by Transient Overexpression of Reprogramming Factors and PDX1 Selection
05/31/2012US20120135010 High affinity human antibodies to human il-4 receptor
05/31/2012US20120135008 Methods and compositions for targeting polyubiquitin
05/31/2012US20120135005 ANTI-TNF-a ANTIBODIES AND THEIR USES
05/31/2012US20120135004 Antibodies to matrix metalloproteinase 9
05/31/2012US20120135003 Anti-ilt7 antibody
05/31/2012US20120134997 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
05/31/2012US20120134993 Compositions and methods for using multispecific-binding proteins comprising an antibody-receptor combination
05/31/2012US20120134992 Mesothelin antibody protein fusions and methods of use
05/31/2012US20120134972 Novel Polypeptides Having Endolysin Activity And Uses Thereof
05/31/2012US20120134970 Viral Vectors Encoding Multiple Highly Homologus Non-Viral Polypeptides And The Use Of Same
05/31/2012US20120134969 Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
05/31/2012US20120134961 Interferon-alpha (IFN-alpha) Fused Protein Having IFN-alpha and Cytoplasmic Transduction Peptide (CTP)
05/31/2012US20120134960 Glycosylated human alpha interferon muteins, method for obtaining them and use
05/31/2012US20120134957 Latent phase viral interleukin-10-(vii-10) and uses thereof
05/31/2012US20120134927 Beta cell marker antibody
05/31/2012US20120134926 Charge-dynamic polymers and delivery of anionic compounds
05/31/2012US20120132527 Use of microfluidic systems in the electrochemical detection of target analytes
05/31/2012CA2818824A1 Treatment of nanog related diseases by inhibition of natural antisense transcript to nanog
05/31/2012CA2818689A1 Novel signal sequences to improve protein expression and secretion of recombinant enzymes and other proteins
05/31/2012CA2818680A1 Engineering of thermotolerant bacillus coagulans for production of d(-)-lactic acid
05/31/2012CA2818581A1 Herbicide resistance gene and use thereof
05/31/2012CA2817415A1 Antibodies that bind notum pectinacetylesterase
05/31/2012CA2810180A1 Brassica gat event dp-073496-4 and compositions and methods for the identification and/or detection thereof
05/30/2012EP2458015A1 Method for providing DNA fragments derived from an archived sample
05/30/2012EP2458010A1 Down-regulation of gene expression using artificial microRNAs
05/30/2012EP2458009A2 Isolated nucleic acid molecule, genetic construct, vector, transgenic cell, method for producing a transgenic cell and plant, isolated and purified polypeptide, biodegradable pesticide composition, pest control method, method for producing transgenic strains resistant to insect pests
05/30/2012EP2458008A1 DNA binding site of a transcriptional activator useful in gene expression
05/30/2012EP2458007A1 DNA binding site of a transcriptional activator useful in gene expression
05/30/2012EP2458006A1 Compounds and methods for modulating expression APOB
05/30/2012EP2458005A1 Fgf21 cis-element binding substance
05/30/2012EP2458004A1 Systems and methods for enhanced scoda
05/30/2012EP2458003A1 Attenuated chimeric flavivirus bearing attenuated jamanese encephalitis virus gene as backbone
05/30/2012EP2458002A1 Method and kit for detection of microorganism
05/30/2012EP2458001A1 High fidelity restriction endonucleases
05/30/2012EP2458000A1 High arachidonic acid producing strains of yarrowia lipolytica
05/30/2012EP2457994A1 Method for inducing differentiation of pluripotent stem cells into cardiomyocytes
05/30/2012EP2457922A1 Altered FAD2 and FAD3 genes in brassica and the molecular marker-assisted detection thereof
05/30/2012EP2457921A2 Aureolic acid derivatives, the method for preparation thereof and the uses thereof
05/30/2012EP2457579A1 Covalently linked interleukin -10
05/30/2012EP2457439A1 Transgenic non-human animals for producing specific isotypes of human antibodies via non-cognate switch regions
05/30/2012EP2456894A1 Sorghum centromere sequences and minichromosomes
05/30/2012EP2456893A1 Sugarcane centromere sequences and minichromosomes
05/30/2012EP2456892A2 Method for sequencing a polynucleotide template
05/30/2012EP2456878A2 Methods and compositions for improving sugar transport, mixed sugar fermentation, and production of biofuels
05/30/2012EP2456877A1 Method for genome editing
05/30/2012EP2456876A2 Genetically modified rat models for cytokine-cytokine signaling pathways
05/30/2012EP2456875A1 Plastid transit peptides derived from lower photosynthetic eukaryotes and methods
05/30/2012EP2456874A1 The use of dimerization domain component stacks to modulate plant architecture
05/30/2012EP2456873A1 Plants with increased yield
05/30/2012EP2456872A1 Improved host cell for the production of a compound of interest
05/30/2012EP2456871A2 Production of erythropoiesis stimulating protein using metal ions
05/30/2012EP2456870A1 Antisense oligomers targeting pcsk9
05/30/2012EP2456869A1 Inhibitors of mtor kinase as anti-viral agents
05/30/2012EP2456868A1 Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
05/30/2012EP2456865A1 Carbohydrate oxidases
05/30/2012EP2456851A1 Fermentative glycerol-free ethanol production
05/30/2012EP2456786A1 Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein
05/30/2012EP2456785A1 Vaccines based on genetic chimera of viral and/or tumoral antigens and vegetable proteins
05/30/2012EP2456777A2 Stambomycin and derivatives, their production and their use as drugs
05/30/2012EP2456432A1 Methods and compositions to reduce oxidative stress
05/30/2012EP2078531B1 Pharmaceutical compositions and methods useful for modulating angiogenesis
05/30/2012EP2076584B1 Genetic cluster of strains of streptococcus thermophilus having appropriate acidifying and texturizing properties for dairy fermentations
05/30/2012EP2064224B1 Tissue culture system for production of hepatitis c virus
05/30/2012EP1993584B1 Inhibitors of CXCR4 activity for use in the treatment of ocular disorders
05/30/2012EP1947460B1 Method of measuring ptx3 with high sensitivity
05/30/2012EP1945797B1 Hepatitis c virus ns2/3 activity assay
05/30/2012EP1915451B1 Method for producing arachidonic acid and/or eicosapentaenoic acid in useful transgenic plants
05/30/2012EP1870460B1 Methods of producing proteins having triple-helix structure
05/30/2012EP1819812B1 The lupac bifunctional marker and its use in protein production
05/30/2012EP1723244B1 Seeds
05/30/2012EP1495116B1 Saccharomyces cerevisiae yeast strain with improved phytase activity
05/30/2012EP1283057B2 Cell proliferation inhibitors
05/30/2012EP1176193B1 Inhibitors for viral infection targeting integrase n-terminal region
05/30/2012CN202246705U Reagent box for extracting nucleic acid according to magnetic bead - micropore plate method
05/30/2012CN1936006B Gene of encoding cell wall mannoprotein and use thereof
05/30/2012CN1932014B Alcohol acetyl transferase gene and use thereof
05/30/2012CN1920043B Cysteine synthase gene and use thereof
05/30/2012CN1919873B Fusion albumen containing HSP70 ATPase structure field and mammal p53 albumen and application thereof
05/30/2012CN1918283B Process for the preparation of l-amino acids using strains of the family enterobacteriaceae
05/30/2012CN1914322B Cell expansion lethal toxin and detection of bacterium belonging to campylobacter genus that targets the same
1 ... 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 ... 4023